Key takeaways
- Digital PCR platforms differ mainly in how they partition a sample: oil-emulsion droplets, droplet arrays, pre-formed nanoplate wells, or microchambers on a chip.
- Independent comparisons in wastewater, genetically modified crops, and protist genetics found leading droplet and nanoplate platforms gave equivalent or similar quantification.
- Differences show up in workflow, throughput, hands-on time, and cost per well, and they depend on batch size.
- Check accepted partitions, not just nominal partitions; one study found a droplet system formed 20,000 droplets but analyzed about 13,400 on average.
- Pilot your own assays and calculate cost per reportable result at your real batch sizes before choosing.
Digital PCR platforms all do the same core job: they split a sample into thousands of partitions, amplify each one, and count how many contain the target. What separates them is how they make the partitions (oil-emulsion droplets, droplet arrays, pre-formed nanoplate wells, or microchambers on a chip), and that choice drives workflow, throughput, and cost more than accuracy.
In a 2026 comparison for wastewater surveillance published in Applied and Environmental Microbiology, a droplet-based system processed 96 samples about 32% faster than a nanoplate system (305 vs. 435 minutes), largely because it cycled all wells at once, while the nanoplate system had about 29% lower consumables cost per well ($4.68 vs. $6.11). Both gave equivalent quantification. If you’re still deciding whether you need digital PCR at all, start with when digital PCR is worth the premium.
The main partitioning approaches
| Approach | How partitions are made | Typical workflow | Things to know |
|---|---|---|---|
Droplet emulsion | Sample is emulsified into thousands of droplets in oil, then cycled and read droplet by droplet | Often multi-step: droplet generation, thermal cycling, and reading on separate or linked instruments | Mature, widely published; droplet counts vary run to run |
Droplet array (crystal or 2D droplets) | Droplets form a monolayer inside a chip chamber and are imaged in place | Partitioning and cycling combined; imaging separate or integrated | Supports multiplexing with imaging readout |
Nanoplate | Pre-formed nanowells in a microfluidic plate | Plate set up like qPCR; partitioning, cycling, and imaging in one instrument | Fixed partition count per well; less hands-on partitioning |
Microchamber chip | Pre-formed chambers on a chip, sometimes with real-time readout | Highly integrated, fast for small batches | Lower per-run capacity on some systems |
One manufacturer’s overview puts typical partition volumes at about 10 nL for nanoplates and 10 to 100 pL for droplets, with partitions per reaction ranging from about 10,000 to far higher depending on the system, as its comparison table shows.
What the head-to-head studies show
Independent comparisons of leading platforms have generally found similar quantitative performance, with differences in workflow and cost:
- Wastewater surveillance. The 2026 Applied and Environmental Microbiology study found equivalent quantification and nearly identical precision, with the differences in speed and cost described above. Hands-on time for master mix preparation was 20 minutes for one 96-well droplet plate compared with 80 minutes for four 24-well nanoplates.
- Genetically modified soybean. A 2025 study in GM Crops & Food found both a droplet and a nanoplate platform met precision requirements for quantifying genetically modified events.
- Gene copy number in protists. A 2025 Scientific Reports study found similar detection and quantification limits and dynamic range for both platforms, and higher precision using a four-base-cutter restriction enzyme, especially on the droplet system.
- Turnaround across three platforms. A comparison of three platforms reported about 6 hours for a multi-instrument droplet system, about 2.5 hours for a droplet array system, and about 1.5 hours for a real-time chip system, with the droplet system able to process more samples per run.
The European Commission Joint Research Centre’s digital PCR working group report offers broader guidance on applying digital PCR, including precision and dynamic range considerations.
Nominal vs. accepted partitions
Partition count drives precision and dynamic range, but the number on the specification sheet isn’t always the number analyzed. In the three-platform comparison, a droplet system that forms about 20,000 droplets produced about 13,409 accepted droplets on average. Nanoplate and chip systems have fixed partition counts but can still lose partitions to filling or imaging issues. When comparing platforms, ask for typical accepted partition counts with real samples, not just nominal capacity.
Specifications that matter
| Specification | Why it matters |
|---|---|
Accepted partitions per reaction | Sets precision and the upper limit of quantification |
Partition volume and uniformity | Affects how concentration is calculated and how consistent results are |
Detection channels | Determines how many targets you can multiplex in one reaction |
Workflow integration | Fewer instruments and steps reduce hands-on time and handling errors |
Samples per run and batch flexibility | Large batches favor some systems; small, frequent runs favor others |
Time to result | Matters for surveillance, clinical, and process decisions |
Consumable cost per well | Often the largest ongoing cost |
Sample input volume | Affects sensitivity for very low-concentration samples |
Software and compliance features | Audit trails and access control matter for regulated work |
Choosing by lab profile
| Lab Profile | What tends to fit | Why |
|---|---|---|
Large batches of 96 samples or more | Systems that cycle full plates in parallel | Throughput advantage for big runs |
Small, frequent runs needing fast results | Integrated nanoplate or chip systems | Less hands-on partitioning and shorter time to result for small batches |
Cost-sensitive, steady volume | Compare consumable cost per well and hands-on time at your batch size | Per-well cost differences add up over thousands of wells |
Multiplex panels | Systems with more detection channels and validated multiplex chemistry | More targets per well, less sample and reagent |
Regulated or clinical work | Platforms with validated methods in your field and compliant software | Reduces validation burden |
Running cost matters as much as instrument price, just as with qPCR; see our breakdown of qPCR running costs for the cost-of-ownership approach, and the overview of PCR platform options for where digital PCR fits.
Evaluating platforms in practice
- Pilot your own assays, including your hardest samples, on each shortlisted platform.
- Time the whole workflow at your real batch size, including setup, partitioning, cycling, reading, and analysis.
- Calculate cost per reportable result, including consumables, hands-on time, failed runs, and service.
- Check field-specific validation, such as published methods for wastewater, GMO testing, or vector titers.
- Confirm multiplexing performance with your target combinations, not vendor examples.
- Review data handling, including export formats and compliance features.
Reporting standards apply whatever platform you choose; see Applying the MIQE Guidelines in a Working qPCR Lab for MIQE and its digital PCR extension, dMIQE.
A digital PCR platform checklist
- Typical batch size and run frequency are defined. Batch size often decides the fastest and cheapest platform. If volumes vary widely, consider whether one flexible system or access to a shared core suits you better.
- Accepted partition counts are verified with real samples. Nominal capacity can overstate what’s analyzed. Ask vendors for typical accepted counts and check them in your pilot.
- Workflow time is measured end to end. Integrated systems reduce hands-on steps but don’t always finish large batches faster. Time your actual workflow, not the brochure’s.
- Cost per well and per reportable result are compared. Consumable prices vary between platforms by meaningful margins. Include hands-on labor and repeats for a fair comparison.
- Multiplexing needs match detection channels. More channels mean more targets per well, but assays must be validated together.
- Field-specific methods are available. Published, validated methods for your application reduce validation effort, particularly in regulated settings.
- Precision levers are understood. Assay design choices, such as restriction enzyme digestion for some genomic targets, can improve precision on any platform.
- Data and compliance needs are covered. Regulated work needs audit trails and controlled access; research labs still benefit from clean, exportable data.
Digital PCR platforms have converged on similar accuracy. The decision now turns on workflow, batch size, and cost per result, so test them the way your lab actually works.
This article was produced under Lab Manager’s AI Editorial Guidelines

















